Abstract
We examined antibody levels and side effects in 90 persons who received human rabies immune globulin made by the Merieux Institute (M-HRIG). In the recommended dose of 20 i.u. kg −1 , M-HRIG appeared to be a safe, medically acceptable product that provided adequate rabies antibody titres while interfering minimally with vaccine-induced antibody. When used in a dose of 44 i.u. kg −1 , M-HRIG caused slight interference with vaccine-induced antibody titres and an unacceptably high rate of reactions.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
